ARKG
ARK Genomic Revolution ETF Equity$31.06
+4.30%
(+1.28)
AUM $1.04B
Expense 75.00%
52w Low $20.25
76.4% of range
52w High $34.39
50d MA $28.33
200d MA $28.49
NAV
$30.62
AUM
$1.04B
Expense
75.00%
Holdings
50
Avg Volume
2.6M
Inception
Oct 30, 2014
Issuer
ARK
Exchange
—
Domicile
US
ISIN
US00214Q3020
50d MA
$28.33
200d MA
$28.49
About
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the Fund’s investment theme of t…
Sector Exposure
Healthcare
99.4%
Financial Services
0.5%
Cash & Others
0.1%
Top Holdings
| Ticker | Name | Weight |
|---|---|---|
| TEM | TEMPUS AI INC-CL A | 9.28% |
| CRSP | CRISPR THERAPEUTICS AG | 8.93% |
| TWST | TWIST BIOSCIENCE CORP | 8.46% |
| TXG | 10X GENOMICS INC-CLASS A | 5.54% |
| ABSI | ABSCI CORP | 5.29% |
| BEAM | BEAM THERAPEUTICS INC | 5.27% |
| ILMN | ILLUMINA INC | 4.34% |
| NTRA | NATERA INC | 4.08% |
| NTLA | INTELLIA THERAPEUTICS INC | 3.84% |
| PSNL | PERSONALIS INC | 3.75% |
| GH | GUARDANT HEALTH INC | 3.58% |
| RXRX | RECURSION PHARMACEUTICALS-A | 3.50% |
| CDNA | CAREDX INC | 3.34% |
| VCYT | VERACYTE INC | 2.65% |
| CMPS | COMPASS PATHWAYS PLC | 2.50% |